SPONSOR
BeOne Medicines
Total Trials
4
Recruiting
4
Phases
Phase 3, Phase 1, Phase 2
Conditions studied: HR+/HER2- Breast CancerB-cell MalignancyRelapsed CancerRefractory CancerB-cell LymphomaRelapsed/Refractory Multiple MyelomaAdvanced Non-Small Cell Lung CancerExtensive-Stage Small Cell Lung Cancer
BeOne Medicines is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including HR+/HER2- Breast Cancer, B-cell Malignancy, Relapsed Cancer, Refractory Cancer.
The trial portfolio spans Phase 3, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — BeOne Medicines
How many clinical trials has BeOne Medicines sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by BeOne Medicines, of which 4 are actively recruiting participants. These trials cover conditions including HR+/HER2- Breast Cancer, B-cell Malignancy, Relapsed Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does BeOne Medicines research focus on?
BeOne Medicines clinical trials span HR+/HER2- Breast Cancer, B-cell Malignancy, Relapsed Cancer, Refractory Cancer, B-cell Lymphoma, and additional conditions. The research pipeline includes Phase 3, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a BeOne Medicines clinical trial?
To participate in a BeOne Medicines trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all BeOne Medicines trials with current recruitment status updated daily.
Clinical Trials by BeOne Medicines
NCT07492641 Phase 3
Recruiting
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
HR+/HER2- Breast Cancer
NCT06634589 Phase 1, Phase 2
Recruiting
A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
B-cell Malignancy
NCT04973605 Phase 1, Phase 2
Recruiting
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
Relapsed/Refractory Multiple Myeloma
NCT07652736
Recruiting
A Study to Investigate Treatment Patterns and Effectiveness of Tislelizumab in European Patients With Resectable or Advanced Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC)
Advanced Non-Small Cell Lung Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology